Literature DB >> 17885860

The development of asthma in wheezing infants with Chlamydia pneumoniae infection.

Masafumi Zaitsu1.   

Abstract

Chlamydia pneumoniae infection might play a role in the pathology of asthma, but its role in infantile asthma remains obscure. The presence of Chlamydia pneumoniae was serologically determined in wheezing infants who were then re-examined 1-year later to determine whether or not asthma is associated with this type of infection. Wheezing infants progressed to asthma more frequently after infection with Chlamydia pneumoniae than those who were not infected. These findings suggested that Chlamydia pneumoniae infection triggers asthma in wheezy infants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885860     DOI: 10.1080/02770900701537115

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  3 in total

Review 1.  Early childhood wheezers: identifying asthma in later life.

Authors:  Anayansi Lasso-Pirot; Silvia Delgado-Villalta; Adam J Spanier
Journal:  J Asthma Allergy       Date:  2015-07-13

Review 2.  Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review.

Authors:  N G Papadopoulos; I Christodoulou; G Rohde; I Agache; C Almqvist; A Bruno; S Bonini; L Bont; A Bossios; J Bousquet; F Braido; G Brusselle; G W Canonica; K H Carlsen; P Chanez; W J Fokkens; M Garcia-Garcia; M Gjomarkaj; T Haahtela; S T Holgate; S L Johnston; G Konstantinou; M Kowalski; A Lewandowska-Polak; K Lødrup-Carlsen; M Mäkelä; I Malkusova; J Mullol; A Nieto; E Eller; C Ozdemir; P Panzner; T Popov; S Psarras; E Roumpedaki; M Rukhadze; A Stipic-Markovic; A Todo Bom; E Toskala; P van Cauwenberge; C van Drunen; J B Watelet; M Xatzipsalti; P Xepapadaki; T Zuberbier
Journal:  Allergy       Date:  2010-11-18       Impact factor: 13.146

Review 3.  Effects of atypical infections with Mycoplasma and Chlamydia on asthma.

Authors:  Gregory Metz; Monica Kraft
Journal:  Immunol Allergy Clin North Am       Date:  2010-09-22       Impact factor: 3.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.